We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 824

Not the end of Weeks but a start
  • Reed Smith LLP
  • USA
  • January 30 2015

It feels like we have been talking about Weeks for years. Two slightly different versions of the same decision have allowed the "innovator liability"


Deflated TwIqbal: New England compounding MDL court won't block vaguebroad claims against health providers
  • Reed Smith LLP
  • USA
  • January 27 2015

Any time you find yourself drawing an analogy to asbestos lawsuits, you know you're in trouble. We have too often heard plaintiff lawyers or, worse


Appeals court sides with FTC in Pom Wonderful advertising case
  • Reed Smith LLP
  • USA
  • February 2 2015

On January 30, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit upheld claims of false advertising by POM


There will be blood (shield laws)
  • Reed Smith LLP
  • USA
  • December 3 2014

It is a pity that the case discussed in today's post did not come out around Halloween. That is not to say that there is anything ghoulish about the


Breaking news - Amarin hits First Amendment home run off FDA
  • Reed Smith LLP
  • USA
  • August 7 2015

Here's a copy of today's 71-page decision in Amarin Pharma, Inc v. FDA, No. 15 Civ. 3588 (PAE), slip op. (S.D.N.Y. Aug.7, 2015), in which the court


Amarin obtains preliminary injunction against FDA regarding off-label and First Amendment issues
  • Reed Smith LLP
  • USA
  • August 7 2015

In our prior posts about Amarin Pharma, Inc. v. FDA, we wondered what the Southern District of New York would make of Amarin's request for an order


When magic words are not
  • Reed Smith LLP
  • USA
  • November 7 2014

One or more of its variants appears in the vast majority of expert reports and transcripts for expert testimony on medical causation: "reasonable


Low wattage reasoning
  • Reed Smith LLP
  • USA
  • April 9 2015

We've already discussed the peculiar decision in Watts v. Medicis Pharmaceutical Corp., 342 P.3d 847 (Ariz App. 2015), once, here. This time, we


Inconvenient (forum) shopping in New Jersey
  • Reed Smith LLP
  • USA
  • December 12 2014

We (in the peculiarly singular sense) last posted on the day after Thanksgiving, a day sometimes referred to as Black Friday because of the number of


Opt-out out of court: Northern District of West Virginia dispatches Lexapro warnings case
  • Reed Smith LLP
  • USA
  • January 29 2015

In Muzichuck v. Forest Laboratories, Inc., No. 1:07-CV-16, 2015 U.S. Dist. LEXIS 5440 (N.D.W.Va. Jan. 16, 2015), the Court considered Defendant’s